Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04254770 · ClinicalTrials.gov registry record · NA

At-Home Care for Subjects With Periodontitis

A NA study, sponsored by Philips Clinical & Medical Affairs Global.

Completed
Registry status
NA
Development phase
346
Enrollment target

NCT04254770: Completed NA study, sponsored by Philips Clinical & Medical Affairs Global.

NCT04254770 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 346 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04254770, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.

COMPLETED
Registry status
NA
Development phase
346 participants
Enrollment target

Study Summary

The effect of use of powered toothbrushing in patients exhibiting periodontal inflammation has been observed repeatedly in clinical studies conducted over a 20+ year period. Whether these subjects also had periodontitis, or not, was not a collected data metric as it was outside the scope of the Investigation. This study, therefore, will specifically include and document that a subject exhibits periodontitis upon study entry, and measure the ensuing response following professional treatment of scaling and root planing, followed by home use of the assigned study products (powered or manual toothbrushing).

Interventions

  • DEVICE ADA approved Manual Toothbrush
  • DEVICE Marketed Power Toothbrush

Trial Details

FieldValue
Enrollment Target 346 participants
Start Date 2020-01-06
Est. Completion 2020-08-10
Phase NA

What the finished NCT04254770 record still lists

NCT04254770 is an interventional study that assigns participants to a tested intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 2 interventions - of which ADA approved Manual Toothbrush is the first listed.

NCT04254770 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04254770 about?

NCT04254770 is a clinical study titled "At-Home Care for Subjects With Periodontitis". The effect of use of powered toothbrushing in patients exhibiting periodontal inflammation has been observed repeatedly in clinical studies conducted over a 20+ year period. Whether these subjects also had periodontitis, or not, was not a collected data metric as it was outside the scope of the Inve...

What is the current status of trial NCT04254770?

This trial is currently completed. It is a NA study. The enrollment target is 346 participants. The study started on 2020-01-06. Estimated completion is 2020-08-10.

What interventions are being tested in trial NCT04254770?

The interventions under investigation include: ADA approved Manual Toothbrush (DEVICE), Marketed Power Toothbrush (DEVICE).

Who is sponsoring clinical trial NCT04254770?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04254770's enrollment target sits among peer trials

346 302nd of 2000 higher than 1,699 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05267886 · 346 participants · Phase 4

    CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

  • NCT06705842 · 346 participants · Phase 4

    APPI-Cost Trial for Perforated Appendicitis

  • NCT06932887 · 346 participants · Phase 3

    The Beat Pain Better Trial

  • NCT01742143 · 347 participants

    Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04254770, the US trial registry maintained by the National Library of Medicine. NCT04254770 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.